Skip to content

All recalls FDA

FDAMedical devicesRecalled Status: Ongoing

Change Healthcare Canada Company recalls Horizon Cardiology Hemo. Version 12.2.

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
A potential issue has been identified in Change Healthcare Cardiology Hemo where incorrect data entry can lead to inaccurate hemodynamic calculations, potentially resulting in misdiagnosis and inappropriate treatment. This issue occurs when the unit of measurement (UOM) for hemoglobin is configured in a way that differs from the users understanding.
Products
  • Horizon Cardiology Hemo. Version 12.2.
Where it was sold

Worldwide distribution - US Nationwide and the countries of Australia, Canada, Germany, Ireland, Israel, United Kingdom.

Nationwide

Units affected
3 systems
About this recall
Horizon Cardiology Hemo. Version 12.2.